Sandesh Seth, Director at RELMADA THERAPEUTICS, INC. (RLMD), bought 9,500 shares at $3.43 ($30K) on 2015-12-15, disclosed to the SEC on 2015-12-17.
Open-market purchase of $30k RLMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.91 | 2,000 | $6K | 19.2% |
| 2 | $3.00 | 2,500 | $8K | 24.7% |
| 3 | $3.30 | 2,500 | $8K | 27.2% |
| 4 | $3.43 | 100 | $343 | 1.1% |
| 5 | $3.50 | 2,400 | $8K | 27.7% |
| Total | $3.19 avg | 9,500 |
| $30K |
| 100% |
| Filing → |
| ATNM | BUY | 2018-04-20 | $2K | — | Filing → |
| ATNM | BUY | 2017-08-04 | $25K | — | Filing → |
| ATNM | BUY | 2017-06-15 | $9K | — | Filing → |